1 / 12

Survey of the availability and prices of Children’s Medicine in Chhattisgarh State

Survey of the availability and prices of Children’s Medicine in Chhattisgarh State. Dr. Antony K.R. Virendra Jain Puni Kokho Dr. Kamlesh Jain State Health Resource Centre, Raipur, Chhattisgarh in collaboration with WHO, WHO, New Delhi. The Objectives … .

lark
Download Presentation

Survey of the availability and prices of Children’s Medicine in Chhattisgarh State

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Survey of the availability and prices of Children’s Medicine in Chhattisgarh State Dr. Antony K.R. Virendra Jain PuniKokho Dr. Kamlesh Jain State Health Resource Centre, Raipur, Chhattisgarh in collaboration with WHO, WHO, New Delhi.

  2. The Objectives… • To document the availability and price of key essential medicines for children in the state of Chhattisgarh, India. • To analyze the components of medicine prices. • How affordable are medicines ? Methodology • 160 outlets were randomly sampled among 28 types of medical dispensing sites in six geography of State. • 50 essential medicines surveyed . • Data analysis tool- WHO-HAI (Health Action International)workbook .

  3. 51 formulations of medicine groups surveyed • Antibiotics- Amoxicillin, Amox+Clav., Azithromycin , Benzyl Pen., Ceftriaxone, Chloramphenicol, Co-trimoxazole, Gentamycin, • Antimalarial - Chloroquine, Quinine, Sulfadoxine+Pyrimethanine, Artemether +Lumefantrine, • Steroids – Prednisolone, Beclomethasone • Anti convulsants- Phenobarbital , Diazepam, Carbamazepine,Phenytoin • Anti-pyretics/anti-inflammatory- Paracetamol & Ibuprofen • Bronchdilators- Salbutamol, Salmetrol+Fluticosone & Spacer device • Anti-tubercular- INH • Anti-helminthic/Anti-protozoal- Albendazole, Metronidazole • Anti-emetic- Promethazine • Micronutrients/Vitamins- Ferrous salt, Zinc, Folic acid, Vit. A • Electrolytes- ORS

  4. Availability of Medicine in Lowest & Highest price

  5. Availability of selected antibiotics in public facilities and retail pharmacies (chemist shops)

  6. Availability of anti-malarials and Oral Rehydration Solution across sectors

  7. Poor availability (<20%) in the private sector of those Medicines not found at all in the public sector .

  8. Median Price Ratio (MPR) in relation to international price-in Lowest & Highest price

  9. Medicines with patient prices of over four times the international reference price in all sectors

  10. Conclusions and lesson learnt… • The average availability of children's medicines was poor in all sectors Specifically for anti-malarials, certain antibiotics, anti-diarrhoeals (zinc) and anti-bacterials in public sector units. • Child friendly formulations like DTs (dispersible tablets),Syrups,drops or suppositories conspicuous by their absence. • For originator brand & branded generic products the total cumulative mark-up from MSP to final price ranged from 34% to 46% whereas for unbranded generics it ranged from 376% to 413%. • Very high retailer’s mark-up for unbranded generic compared to originator brand/branded generic (well within the Govt.capping of 15% mark ups for wholesalers and 35% for retailers) • Public procurement of medicines is at reasonable efficiency of prices that are just under international reference prices (MPR = 0.96). • But, in private sector certain medicines cost several times higher.

  11. Impact of Study Future Research Agenda • Field-based drug research to determine optimum utilization and supply projection. • Why very high mark up for retailers for unbranded generic drugs? • Operational research on mechanisms to prevent flooding of poor-quality and counterfeit drugs. • Comparative study of other State scenario using similar methodology • Strong political will resulting in a good State drug policy is emerging • Two Orientation workshops for stakeholders conducted. • Inclusion of child friendly formulations in State EML (Revised EML 2010) on 31 December 2010. (refer www.cghealth.nic.in) • Setting up the Chhattisgarh Medical Services Corporation (CGMSC) for improved procurement and logistics.

  12. Thank You…

More Related